Welcome to Drug and Therapeutics Bulletin (DTB)

For over 45 years, Drug and Therapeutics Bulletin (DTB) has provided rigorous and independent evaluations of, and practical advice on, individual treatments and the overall management of disease for doctors, pharmacists and other healthcare professionals.

DTB has always been wholly independent of the pharmaceutical industry, Government and regulatory authorities. DTB is also free of advertising and other forms of commercial sponsorship.

This month's issue

September 2010

The price you pay
Management of corticosteroid-induced osteoporosis
What role for ▼Qlaira in contraception?
A guide to health economic evaluations
Don't Drop Mixtard 30 campaign
Podcast: In this issue - September 2010

Don't Drop Mixtard 30

Important links for our campaign
Mixtard 30 - going, going, gone? >>
Online Poll >>
Podcast: Mixtard 30 >>
Sign the online petition >>

Follow us on Twitter

You can now keep up to date with the latest DTB articles via our Twitter account


Follow DTB on Twitter >>

Survey on Herbal Medicines

View the results of the recent DTB survey on Herbal Medicines

View results >>

Subscribe today!

Keep up to date for as little as £63 / $123 / €85 per year

Subscribe >>

Contribute

Interested in making an impact on prescribing practice by contributing to DTB?

Register your interest here >>